These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7987874)

  • 1. Wavelength index: a predictor of the response to disopyramide in paroxysmal lone atrial fibrillation.
    Kumagai K; Gondo N; Matsuo K; Annoura M; Moroe K; Nakashima Y; Hiroki T; Arakawa K
    Cardiology; 1994; 85(3-4):184-92. PubMed ID: 7987874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of disopyramide on initiation of atrial fibrillation and relation to effective refractory period.
    Ito M; Onodera S; Hashimoto J; Noshiro H; Shinoda S; Nagashima M; Suzuki H
    Am J Cardiol; 1989 Mar; 63(9):561-6. PubMed ID: 2919560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased AAI mode pacing threshold after termination of atrial fibrillation by acute administration of disopyramide phosphate.
    Anzawa R; Ishikawa S; Tanaka Y; Okazaki F; Mochizuki S
    Europace; 2006 May; 8(5):345-8. PubMed ID: 16635993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological mechanism of combination therapy with disopyramide and propranolol for paroxysmal atrial fibrillation.
    Gondo N; Kumagai K; Yamanouchi Y; Annoura M; Saku K
    J Cardiol; 2000 Dec; 36(6):405-10. PubMed ID: 11190584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
    Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
    Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
    Bennett DH
    Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of disopyramide in the treatment of atrial flutter with overdrive pacing].
    Della Bella P; Marenzi G; Doni F; Tondo C; Cipolla C; Grazi S; Rimondini A; Salvioni A; Guazzi MD
    Cardiologia; 1989 Mar; 34(3):247-52. PubMed ID: 2743366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial pacing failure following termination of atrial fibrillation by acute administration of disopyramide phosphate.
    Anzawa R; Ishikawa S; Tanaka Y; Okazaki F; Mochizuki S
    J Interv Card Electrophysiol; 2005 Jun; 13(1):51-3. PubMed ID: 15976979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of disopyramide on atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Fujimura O; Klein GJ; Sharma AD; Yee R; Szabo T
    J Am Coll Cardiol; 1989 Apr; 13(5):1133-7. PubMed ID: 2926064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of class Ia antiarrhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics.
    Fujiki A; Yoshida S; Tani M; Inoue H
    Am J Cardiol; 1994 Aug; 74(3):282-3. PubMed ID: 8037138
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
    Camm J; Ward D; Spurrell RA
    Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation.
    Kubara I; Ikeda H; Hiraki T; Yoshida T; Ohga M; Imaizumi T
    J Cardiovasc Electrophysiol; 1999 May; 10(5):670-9. PubMed ID: 10355923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of disopyramide on the atrial fibrillation threshold in the human atrium.
    Ishibashi K; Inoue D; Sakai R; Inoue M; Shirayama T; Asayama J; Nakagawa M
    Int J Cardiol; 1995 Nov; 52(2):177-84. PubMed ID: 8749880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Abe N; Kameda K; Owada S; Tomita H; Oikawa K; Okumura K
    J Cardiol; 2003 Apr; 41(4):191-8. PubMed ID: 12728540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of termination and perpetuation of atrial fibrillation.
    Asano Y; Saito J; Matsumoto K; Kaneko K; Yamamoto T; Uchida M
    Am J Cardiol; 1992 Apr; 69(12):1033-8. PubMed ID: 1561974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery.
    Komatsu T; Tachibana H; Satoh Y; Ozawa M; Kunugita F; Tashiro A; Okabayashi H; Nakamura M
    Circ J; 2010 Sep; 74(9):1859-65. PubMed ID: 20631453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D; Opolski G; Torbicki A
    Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapy with disopyramide phosphate: side effects and effectiveness.
    Bauman JL; Gallastegui J; Strasberg B; Swiryn S; Hoff J; Welch WJ; Bauernfeind RA
    Am Heart J; 1986 Apr; 111(4):654-60. PubMed ID: 3082173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral repetitive loading of disopyramide on acute-onset atrial fibrillation with concurrent monitoring of serum drug concentration.
    Kishikawa T; Maruyama T; Kaji Y; Sasaki Y; Kanaya S; Fujino T; Niho Y; Ishihara Y
    Int J Cardiol; 1999 Jan; 68(1):57-62. PubMed ID: 10077401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.